Phase 2 Gallbladder Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Recurrent Mucosal MelanomaMucosal MelanomaAnal Melanoma+14 more
National Cancer Institute (NCI)101 enrolled147 locationsNCT05111574
Recruiting
Phase 2
Agnostic Therapy in Rare Solid Tumors
Cancer of Unknown PrimarySoft Tissue SarcomaCholangiocarcinoma+38 more
Instituto do Cancer do Estado de São Paulo28 enrolled8 locationsNCT06638931
Recruiting
Phase 2
Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Esophageal AdenocarcinomaGastric AdenocarcinomaPancreas Adenocarcinoma+6 more
Yale University54 enrolled1 locationNCT07282912
Recruiting
Phase 2
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+2 more
Case Comprehensive Cancer Center27 enrolled2 locationsNCT07146646
Recruiting
Phase 2Phase 3
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
Ovarian NeoplasmsColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK30 enrolled27 locationsNCT05786716
Recruiting
Phase 2
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine102 enrolled2 locationsNCT04183712
Recruiting
Phase 2Phase 3
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Gallbladder Cancer
Banaras Hindu University56 enrolled1 locationNCT05833815
Recruiting
Phase 2
A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs
Unresectable Gallbladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37 enrolled1 locationNCT06423170
Recruiting
Phase 2
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD50 enrolled1 locationNCT05757336
Completed
Phase 2
A phase II trial of gemcitabine in a fixed dose rate infusion combined with cisplatin in patients with operable biliary tract carcinomas
Adenocarcinoma of the gallbladder or intra/extrahepatic bile ducts
AGITG/ NHMRC Clinical Trials Centre45 enrolled1 locationACTRN12605000001695